Cadila Healthcare net profit up 29 percent to Rs 587 crore in Q1
Advertisement
New Delhi: Drug firm Cadila Healthcare on Wednesday reported a 29.33 per cent rise in its consolidated net profit to Rs 587.2 crore for the quarter ended on June 30, 2021, mainly on account of robust sales in the Indian market.
The company had posted a net profit of Rs 454 crore for the corresponding period of the previous fiscal, Cadila Healthcare said in a regulatory filing.
Consolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the same period a year ago, it added.
The company's India business comprising human formulations and consumer wellness business contributed 50 per cent of consolidated revenues during the quarter. It witnessed a strong growth of 43 per cent on a y-o-y basis, posting sales of Rs 1,943 crore during the quarter, the filing said.
The company's business in the US posted sales of Rs 1,451 crore. The company's rest of the world business grew by 17 per cent during the quarter on a y-o-y basis and posted sales of Rs 277 crore, it added.
Read also: Zydus Cadila ZyCoV-D likely to get emergency use nod this week: Sources
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.